PL1916913T3 - Preparat białkowy do leczenia uwarunkowanego fizjologicznie klinicznie nie zwracającego uwagi, zwiększonego zapotrzebowania na białko - Google Patents

Preparat białkowy do leczenia uwarunkowanego fizjologicznie klinicznie nie zwracającego uwagi, zwiększonego zapotrzebowania na białko

Info

Publication number
PL1916913T3
PL1916913T3 PL06778335T PL06778335T PL1916913T3 PL 1916913 T3 PL1916913 T3 PL 1916913T3 PL 06778335 T PL06778335 T PL 06778335T PL 06778335 T PL06778335 T PL 06778335T PL 1916913 T3 PL1916913 T3 PL 1916913T3
Authority
PL
Poland
Prior art keywords
protein
treating
increased need
clinically normal
protein composition
Prior art date
Application number
PL06778335T
Other languages
English (en)
Inventor
Armand Herberger
Original Assignee
Armand Herberger
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Armand Herberger filed Critical Armand Herberger
Publication of PL1916913T3 publication Critical patent/PL1916913T3/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17—Amino acids, peptides or proteins
    • A23L33/175—Amino acids
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17—Amino acids, peptides or proteins
    • A23L33/18—Peptides; Protein hydrolysates
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17—Amino acids, peptides or proteins
    • A23L33/185—Vegetable proteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Polymers & Plastics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Diabetes (AREA)
  • Food Science & Technology (AREA)
  • Nutrition Science (AREA)
  • Mycology (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Obesity (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Endocrinology (AREA)
  • Emergency Medicine (AREA)
  • Hematology (AREA)
  • Molecular Biology (AREA)
  • Epidemiology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
PL06778335T 2005-08-23 2006-08-23 Preparat białkowy do leczenia uwarunkowanego fizjologicznie klinicznie nie zwracającego uwagi, zwiększonego zapotrzebowania na białko PL1916913T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP05018276 2005-08-23
EP06778335A EP1916913B1 (de) 2005-08-23 2006-08-23 Proteinzusammensetzung zur behandlung eines physiologisch bedingten, klinisch unauffälligen proteinmehrbedarfs
PCT/EP2006/065611 WO2007023172A2 (de) 2005-08-23 2006-08-23 Proteinzusammensetzung zur behandlung eines physiologisch bedingten, klinisch unauffälligen proteinmehrbedarfs

Publications (1)

Publication Number Publication Date
PL1916913T3 true PL1916913T3 (pl) 2011-04-29

Family

ID=35276227

Family Applications (1)

Application Number Title Priority Date Filing Date
PL06778335T PL1916913T3 (pl) 2005-08-23 2006-08-23 Preparat białkowy do leczenia uwarunkowanego fizjologicznie klinicznie nie zwracającego uwagi, zwiększonego zapotrzebowania na białko

Country Status (5)

Country Link
EP (1) EP1916913B1 (pl)
AT (1) ATE487390T1 (pl)
DE (1) DE502006008291D1 (pl)
PL (1) PL1916913T3 (pl)
WO (1) WO2007023172A2 (pl)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2011078654A1 (en) 2009-12-24 2011-06-30 N.V. Nutricia Low-caloric high-protein nutritional composition for the stimulation of muscle protein synthesis
WO2013148329A1 (en) * 2012-03-26 2013-10-03 Pronutria, Inc. Charged nutritive proteins and methods
JP2015519878A (ja) 2012-03-26 2015-07-16 プロニュートリア・インコーポレイテッドＰｒｏｎｕｔｒｉａ， Ｉｎｃ． 栄養断片、タンパク質、および方法
JP2015518470A (ja) 2012-03-26 2015-07-02 プロニュートリア・インコーポレイテッドＰｒｏｎｕｔｒｉａ， Ｉｎｃ． 栄養タンパク質および方法
WO2013148330A1 (en) 2012-03-26 2013-10-03 Pronutria, Inc. Nutritive fragments, proteins and methods
EP3048904A2 (en) * 2013-09-25 2016-08-03 Pronutria Biosciences, Inc. Compositions and formulations for treatment of gastrointestinal tract malabsorption diseases and inflammatory conditions and methods of production and use thereof

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5132113A (en) * 1990-10-26 1992-07-21 Maurizio Luca Nutritional composition containing essential amino acids
US5242697A (en) * 1990-10-26 1993-09-07 Maurizio Luca Method of preparing nutrified food products
GB0110288D0 (en) * 2001-04-26 2001-06-20 Novartis Nutrition Ag Composition and treatment method
DE60329744D1 (de) * 2002-02-22 2009-12-03 Ajinomoto Kk Aminosäurepulver und verfahren zu seiner herstellung
US7037522B2 (en) * 2002-09-27 2006-05-02 Western Holdings, L.L.C. Nocturnal muscle enhancing composition and method
JP4970694B2 (ja) * 2002-12-02 2012-07-11 株式会社明治 持続性筋肉疲労改善剤
KR20050089857A (ko) * 2002-12-26 2005-09-08 아지노모토 가부시키가이샤 간암 발생 및 진행 억제제

Also Published As

Publication number Publication date
WO2007023172A2 (de) 2007-03-01
ATE487390T1 (de) 2010-11-15
EP1916913A2 (de) 2008-05-07
EP1916913B1 (de) 2010-11-10
WO2007023172A3 (de) 2007-09-07
DE502006008291D1 (de) 2010-12-23

Similar Documents

Publication Publication Date Title
WO2005023866A3 (en) Peptides that inhibit complement activation
BR9906438A (pt) Composição de reforço nutricional apropriada para o tratamento de úlceras de pressão
GEP20125565B (en) Lactam compounds and their pharmaceutical use
EP1614675A3 (en) Amino acids with affinity for the alpha-2-delta protein
EP2085096A3 (en) Novel composition and methods for the treatment of immune related diseases
NZ617196A (en) Activin-actrii antagonists and uses for increasing red blood cell levels
EP2065040A3 (en) Sphingolipids against pathological processes in lipid rafts
WO2005023185A3 (en) Pharmaceutical compositions and method of using levodopa and carbidopa
WO2006068729A3 (en) Methods and compositions for enhancing iron absorption
WO2007022518A3 (en) New uses of glucoregulatory proteins
MXPA05014082A (es) Acidos biariloximetilarenocarboxilicos.
SE0501556L (sv) Förstärkt absorption
UA86937C2 (ru) Композиция, которая содержит лактат и калий, и ее применение
TW200621765A (en) Substituted phenylaminothiazoles and their use
EP2241196A3 (en) Nutritional supplement comprising oligosaccharides and cysteine for treating hiv
TW200603746A (en) Iron sulfate based phosphate adsorbent
WO2007023172A3 (de) Proteinzusammensetzung zur behandlung eines physiologisch bedingten, klinisch unauffälligen proteinmehrbedarfs
DE50207740D1 (de) Verwendung von phosphatidylserin zur behandlung des aufmerksamkeits-defizit-syndroms (adhs)
NZ541231A (en) A method of treatment or prophylaxis of symptoms of herpes viral infection
GEP20063821B (en) Orodispersible pharmaceutical composition comprising perindopril
EA200801305A1 (ru) Применение циклетанина и других фуропиридинов для лечения гипертензии с преобладанием систолического давления, изолированной систолической гипертензии, повышенного пульсового артериального давления и общей гипертензии
MXPA04005033A (es) Composicion farmaceutica que comprende una combinacion de metformina y acido 4-oxobutanoico y el uso de la misma para el tratamiento contra diabetes.
WO2007027092A3 (en) Oral composition for moisturising skin
HUE009867T4 (hu) Amlodipin-bezilátot és lizinopril-dihidrátot tartalmazó gyógyszerkészítmény és eljárás annak elõállítására
TW200505831A (en) Arylcycloalkyl derivatives having branched side chains, processes for their preparation and their use as pharmaceuticals